Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 15 - Drugs for genital or sexual disorders; Contraceptives
Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
10/2003
10/16/2003US20030195251 For therapy of psychiatric, pain and other disorders
10/16/2003US20030195241 Mitogen-activated protein kinase inhibitors used for prophylaxis of cancer, inflammatory and cardiovascular disorders, and as coatings for medical equipments such as stents
10/16/2003US20030195235 Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators
10/16/2003US20030195230 Substituted amine derivatives and methods of use
10/16/2003US20030195222 Substituted pyrimidinones and pyrimidinthiones
10/16/2003US20030195220 Preparations for oral administration
10/16/2003US20030195215 Compounds effective as beta-2 adrenoreceptor agonists as well pde4-inhibitors
10/16/2003US20030195214 Cancer treatment
10/16/2003US20030195212 An amide derivatives for treating obesity, anorexia, inflammation, mental diseases associated with the melanocyte stimulating hormones
10/16/2003US20030195210 An enzyme inhibitors of cyclic guanosine 3',5'-monophophate-metabolizing phosphodiesterases; treating cardiovascular disorders, brian disorders, Alzheimer's disease, urogenital or sexual disorders
10/16/2003US20030195186 Administration of a therapeutically effective amount of at least one acetylcholinesterase inhibitor
10/16/2003US20030195177 Method of treating hormonal deficiencies in women undergoing estrogen replacement therapy
10/16/2003US20030195169 Such as (S)-phosphoric acid mono-(3-(5-chloro-2-methoxy-phenyl)-3-fluoro-2-oxso-6-trifluoromethyl-2,3 -dihydro-indol-1-ylmethyl)ester; for modulation of large-conductance calcium-activated potassium (BK) channels
10/16/2003US20030195165 Comprises arginine as nitric oxide donor; synergistic; contains no adenosine and/or linsidomine
10/16/2003US20030195160 Sodium channel blockers
10/16/2003US20030194390 Alkyl cyanoacrylate and inhibitor and aggregate structure formed; alkyl fatty ester, opacifier; ablating tissue by blocking blood flow
10/16/2003US20030194389 Occlusive composition
10/16/2003CA2694410A1 Pyridinoylpiperidines as 5-ht1f agonists
10/16/2003CA2481392A1 Terphenyl derivatives, preparation thereof, compositions containing same
10/16/2003CA2481028A1 Hormone replacement therapy
10/16/2003CA2480818A1 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy
10/16/2003CA2480579A1 Embolization
10/15/2003EP1352972A2 Methods of identifying a pharmaceutically active compound for the treatment of a condition caused by altered expression of the insulin receptor
10/15/2003EP1352658A1 Preventives or remedies for endometriosis
10/15/2003EP1351962A2 Thienopyrimidine
10/15/2003EP1351961A1 Substituted indolines as 5-ht receptor ligands
10/15/2003EP1351953A1 Quinoline derivatives as nk-3 antagonists
10/15/2003EP1351941A1 Bisaryl derivatives having fsh receptor modulatory activity
10/15/2003EP1351934A1 Naphthalene derivatives which bind to the ep4 receptor
10/15/2003EP1351929A1 Nitric oxide synthase inhibitor phosphate salt
10/15/2003EP1351916A2 Ether compounds and compositions for cholesterol management and related uses
10/15/2003EP1351690A2 Method of treatment of dopamine-related dysfunction through administration of a full d1 dopamine receptor agonist and with no induction of tolerance
10/15/2003EP1351683A2 Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser
10/15/2003EP1228041B1 Indole derivatives and their use as 5ht2a ligands
10/15/2003EP1173181B1 Composition comprising phosphodiesterase inhibitors for the treatment of sexual dysfunction
10/15/2003EP0758644B1 Sulfonyl- or sulfinyl-benzoyl-guanidine derivatives
10/15/2003CN1449445A Ev-vegf nucleic acids and polypeptides and methods of use
10/15/2003CN1449380A Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors
10/15/2003CN1449287A Fused pyrrolocarbazoles against inflammation
10/15/2003CN1448498A Health preserving wine and its making method
10/15/2003CN1448175A Prep. of Chinese angelica medicine component
10/15/2003CN1448170A Chinese medicine for treating dermatopathy and gynecopathy disease and its preparing process
10/15/2003CN1448167A Medicine for treatment of pelvic inflammation, its preparation and preparing method
10/15/2003CN1448162A Female external sterilization film
10/15/2003CN1448140A Sea urchin containing preparation and its preparing method
10/15/2003CN1124262C Indole derivatives useful as endothelin receptor antagonists
10/15/2003CN1124143C Pregnancy promoting medicine for treating hyperprolactinemia sterility and its preparation
10/15/2003CN1124137C Condensation polymer composition for preventing pregnancy
10/14/2003US6632920 Immunology; diagnosing cancer, nervous system, brain, sleep, psychological, and disorders
10/14/2003US6632829 Thienyl, furyl and pyrrolyl-sulfonamides, useful for treating hypertension, cardiovascular disease, asthma, pulmonary hypertension, inflammatory diseases, vision defects, menstrual disorders, renal failure and other diseases
10/14/2003US6632419 Increasing libido in humans via acute testosterone administration
10/14/2003CA2122911C 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents
10/09/2003WO2003082866A1 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
10/09/2003WO2003082853A1 New compounds
10/09/2003WO2003082839A1 (4,2-disubstituted-thiazol-5-yl)amine compounds as pde7 inhibitors
10/09/2003WO2003082808A1 Benzamide derivatives
10/09/2003WO2003082807A2 Amino acids with affinity for the alpha-2-delta-protein
10/09/2003WO2003082360A1 Drug delivery particle
10/09/2003WO2003082336A1 Female birth control method
10/09/2003WO2003082320A1 Novel screening method
10/09/2003WO2003082314A2 Diagnostics and therapeutics for diseases associated with n-formyl peptide receptor like 1 (fprl1)
10/09/2003WO2003082312A1 Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia
10/09/2003WO2003082306A1 Lactobacillus iners for the enhancement of urogenital health
10/09/2003WO2003082299A1 Improved hormone replacement therapy
10/09/2003WO2003082278A1 Thiazolidine carboxamide derivatives as modulators of the prostaglandin f receptor
10/09/2003WO2003082277A1 Thiazol-2-yl-imine compounds as pde-7 inhibitors
10/09/2003WO2003082274A1 Angiogenesis inhibitors
10/09/2003WO2003082271A2 Indole derivatives having anti-angiogenetic activity
10/09/2003WO2003082256A2 Use of a cb1 cannabinoid receptor antagonist for producing medicaments which are useful for treating sexual behaviour problems and/or for improving sexual performances
10/09/2003WO2003082193A2 Suramin and derivatives thereof as topical microbicide and contraceptive
10/09/2003WO2003049804A3 Treatment of genitourinary tract disorders
10/09/2003WO2003037367A3 New bacterium causing poultry disease and vaccine derived thereof
10/09/2003WO2003035686A3 Compositions of fsh with high sialylation degree and their use for the preparation of medicaments
10/09/2003WO2003024465A3 Use of extracts of the genus cimicifuga as organoselective medicines
10/09/2003WO2003013534A3 Methods for the treatment of cancer with irinotecan based on cyp3a5
10/09/2003WO2003013533A3 Methods for improved treatment of cancer with irinotecan based on mrp1
10/09/2003WO2002092004A3 Use of hmg fragment as anti-inflammatory agents
10/09/2003WO2002083627A3 Ligands des integrins avss6
10/09/2003WO2002078682A3 Estrogen replacement therapy
10/09/2003WO2002077017A3 Medical uses of intercellular communication facilitating compounds
10/09/2003WO2002015841A3 Medicine for treating female sexual dysfunction by acting on the central nervous system
10/09/2003US20030191308 Quinazoline compounds
10/09/2003US20030191178 Therapy for vision defects; hypotensive agents; respiratory system disorders
10/09/2003US20030191167 Autoimmune disease, antiarthritic agents, antiallergens, anticancer agents
10/09/2003US20030191136 Melanin concentrating hormone receptor ligands
10/09/2003US20030191126 Psychological disorders; antidepressants
10/09/2003US20030191103 Hormone replacement therapy
10/09/2003US20030191102 Contraception method using competitive progesterone antagonists and novel compounds useful therein
10/09/2003US20030191099 Antiestrogen compound
10/09/2003US20030191097 Hormone replacement therapy
10/09/2003US20030191065 Insulin-like growth factor; genetic engineering; central nervous system disorders
10/09/2003US20030190708 Novel hepatoma-derived growth factor-like proteins, polynucleotides encoding them and methods of use
10/09/2003US20030190707 17 human secreted proteins
10/09/2003US20030190687 Interacts with human DR5 to produce agonistic or antagonistic effects including inhibition of cell proliferation and apoptosis; used to treat apoptosis-related disease and unregulated cell growth
10/09/2003US20030190685 Bind to Tumor Necrosis Factor(TNF)-Related Apoptosis Inducing Ligand (TRAIL) receptors ; used in the prevention and treatment of cancers and other proliferative disorders
10/09/2003US20030190375 Therapeutical use of sophora flavescens or sophora subprostrata extracts
10/09/2003CA2480695A1 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
10/09/2003CA2480679A1 (4,2-disubstituted-thiazol-5-yl)amine compounds as pde7 inhibitors
10/09/2003CA2480632A1 Drug delivery particle
10/09/2003CA2480568A1 Thiazol-2-yl-imine compounds as pde-7 inhibitors
1 ... 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 ... 557